Daily Policy Digest
Health Issues
| The Role of Regulation and Distribution Channel in Drug Safety Substandard drugs are priced 30.3 percent lower than comparable generics in the same city but counterfeits offer almost no discount relative to the genuine version they aim to mimic... |
| Growth of Consumer-Directed Could Save Billions Annually In the next decade, consumer-directed health plan enrollment could total 50 percent of the total employer-sponsored enrollment, saving the nation $57.1 billion annually in health care expenditures... |
| Nurse Practitioners Look to Fill Gap with Expected Spike in Demand for Health Services According to the Association of American Medical Colleges, the country will have 63,000 too few doctors as soon as 2015... |
| How Not to Cure Chronic Diseases Drug manufacturers recoup their research and development costs for only one in five approved drugs -- a decline from the one in four figure of about a decade ago... |
| Obama Health Plan Will Squeeze the Middle Class For a family of four, premiums on even one of the lower priced "silver" options could still cost more than $15,000 annually on the new health insurance exchanges... |
| Why Nurses Need More Authority The Association of American Medical Colleges predicts a shortfall of 29,800 primary care physicians by 2015 and 65,800 by 2025... |
| Will Americans Ever Control as Many of Their Own Health Dollars as Others? In 2008, the United States had one of the lowest percentages of total health care spending that was directly controlled by consumers among developed countries... |
| Health Insurers to Pay Rebates Rebates from health insurance companies that do not meet medical loss ratio requirements will total more than $1 billion this year... |
| Job-Based Health Coverage to Become Even More Expensive under Affordable Care Act The 71 Fortune 100 companies that responded to a House Ways and Means Committee survey could save an estimated $28.6 billion in 2014 alone by eliminating health insurance coverage for their more than 5.9 million U.S. employees... |
| State Reform of Medicaid Drug Programs Lobbyists often obstruct state efforts to reform Medicaid drug programs, says Devon Herrick, a senior fellow with the National Center for Policy Analysis... |
